Company Filing History:
1 out of 1,391 
1 out of 11 Years Active: 1997
Title: Jacob Eval: Innovator in Thrombospondin Analog Research
Introduction
Jacob Eval is a notable inventor based in Baltimore, MD (US), recognized for his contributions to the field of therapeutic agents. He holds a patent that focuses on synthetic analogs of thrombospondin, which are crucial for various medical applications. His work has the potential to impact therapeutic strategies significantly.
Latest Patents
Jacob Eval's patent, titled "Synthetic analogs of thrombospondin and therapeutic use thereof," presents compounds and compositions that comprise fragments and synthetic analogs of human thrombospondin. This patent outlines methods for utilizing these agents as thrombospondin-like therapeutic options, showcasing his innovative approach to medical science.
Career Highlights
Throughout his career, Jacob has worked with prominent organizations, including W.R. Grace & Co. and The Medical College of Pennsylvania. His experience in these institutions has allowed him to develop and refine his research in the field of thrombospondin analogs.
Collaborations
Jacob has collaborated with notable individuals in his field, including Bruce King Hamilton and George Paul Tuszynski. These partnerships have contributed to the advancement of his research and the successful development of his patent.
Conclusion
Jacob Eval's work in synthetic analogs of thrombospondin represents a significant advancement in therapeutic applications. His innovative research and collaborations highlight his commitment to improving medical treatments through scientific discovery.